BDNF & cognitive research
Semax has been studied for upregulation of BDNF and NGF expression in pre-clinical models. Female cohorts are referenced in cognitive-performance and memory-task research.
Longevity
Semax
Cognition & neuroprotection research
A synthetic heptapeptide analog of ACTH(4-10) developed in Russia, studied for nootropic, neuroprotective and BDNF-modulating effects.
$39.99per vial · research use
Quantity
Up to 50%
- BDNF expression studies
- Cognitive performance research
- Neuroprotection models
For research use only. Not for human consumption.
Women's research notes
What researchers study Semax for in women
Semax pre-clinical and clinical research is referenced in women's studies of cognitive performance, mood regulation and stress resilience — domains with documented sex-based differences.
Mood & stress-axis research
Sex-based differences in HPA-axis reactivity are well-documented. Semax has been examined in stress-resilience and anxiety-model research that includes female pre-clinical cohorts.
Neuroprotection & recovery
Clinical research from Russian neurology institutes has examined Semax in ischemic-event recovery cohorts that include female participants.
Selected literature
- Ashmarin IP, et al. Neurosci Behav Physiol 2005 — Semax pharmacology
- Dolotov OV, et al. J Neurochem 2006 — Semax and BDNF expression
Information below summarizes published pre-clinical and clinical research. It is provided for educational purposes for qualified researchers and is not medical advice, a treatment recommendation, or a claim of efficacy. Products are sold for research use only.
